CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-29 | YANG MICHAEL J. EVP and CCO | Grant or award · Stock Options (Right to Buy) | +59,042 | 59,042 | ||
| 2019-04-29 | YANG MICHAEL J. EVP and CCO | Grant or award · Restricted Stock Units | +16,827 | 16,827 | ||
| 2019-04-29 | Ridloff Elena EVP and CFO | Grant or award · Stock Options (Right to Buy) | +45,547 | 45,547 | ||
| 2019-04-29 | Ridloff Elena EVP and CFO | Grant or award · Restricted Stock Units | +12,981 | 12,981 | ||
| 2019-04-29 | KIM AUSTIN D. EVP & General Counsel | Grant or award · Stock Options (Right to Buy) | +42,173 | 42,173 | ||
| 2019-04-29 | KIM AUSTIN D. EVP & General Counsel | Grant or award · Restricted Stock Units | +12,019 | 12,019 | ||
| 2019-04-29 | Stankovic Srdjan R. President | Grant or award · Stock Options (Right to Buy) | +134,953 | 134,953 | ||
| 2019-04-29 | Stankovic Srdjan R. President | Grant or award · Restricted Stock Units | +38,462 | 38,462 | ||
| 2019-04-29 | DAVIS STEPHEN President and CEO | Grant or award · Stock Options (Right to Buy) | +219,298 | 219,298 | ||
| 2019-04-29 | DAVIS STEPHEN President and CEO | Grant or award · Restricted Stock Units | +62,500 | 62,500 | ||
| 2019-04-01 | Ridloff Elena EVP and CFO | Grant or award · Restricted Stock Units | +40,000 | 40,000 | ||
| 2019-01-09 | Brege Laura Director | Option exercise | +10,000 | $2.16 | $22K | 10,000 |
| 2019-01-09 | Brege Laura Director | Sale | −10,000 | $20.00 | $200K | 0 |
| 2019-01-09 | Brege Laura Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2018-11-30 | BAKER BROS. ADVISORS LP Director | Purchase | +585,882 | $17.00 | $10.0M | 3,736,902 |
| 2018-11-30 | BAKER BROS. ADVISORS LP Director | Purchase | +11,178,823 | $17.00 | $190.0M | 35,976,940 |
| 2018-11-30 | BAKER BROS. ADVISORS LP Director | Other disposition | −489,977 | 0 | ||
| 2018-11-30 | BAKER BROS. ADVISORS LP Director | Other acquisition | +71,647 | 71,647 | ||
| 2018-11-30 | BAKER BROS. ADVISORS LP Director | Other acquisition | +71,647 | 71,647 | ||
| 2018-11-30 | BAKER BROS. ADVISORS LP Director | Other disposition · Common Stock Warrant (right to buy) | −10,731 | 0 |
Page 45 of 63 · 1,260 trades